東洋

+0.10 (+0.13%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

77.50569成交張數11.12本益比2.77股價淨值比5.81%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	118	70	34.5%	2.13	27.97	26.4%	15.4%	2.1	2.0
2026Q1	117	66	36.6%	1.71	26.42	25.4%	14.2%	6.5	6.5
2025Q4	113	72	29.0%	2.28	29.11	22.3%	14.0%	7.8	7.6
2025Q3	115	69	33.6%	2.01	27.60	27.4%	16.1%	3.2	2.7
2025Q2	107	62	35.1%	1.77	24.87	26.4%	15.1%	2.6	2.5
2025Q1	110	61	37.2%	1.63	24.61	26.9%	14.8%	4.0	3.9
2024Q4	109	68	30.9%	2.02	27.15	22.8%	14.0%	8.0	7.8
2024Q3	106	62	34.5%	1.77	24.97	18.6%	10.9%	1.0	0.8
2024Q2	102	58	36.5%	1.85	23.35	20.1%	11.3%	1.0	0.8
2024Q1	101	55	39.2%	1.75	22.06	22.2%	11.9%	3.5	3.3
2023Q4	99	59	34.1%	2.08	23.89	19.5%	11.6%	5.7	5.5
2023Q3	100	58	35.7%	1.96	23.42	20.7%	11.8%	0.7	0.5
2023Q2	96	54	38.3%	1.54	21.66	21.7%	11.9%	2.2	2.1
2023Q1	96	50	41.2%	1.41	20.31	21.1%	11.7%	2.2	2.2
2022Q4	96	57	35.1%	1.73	22.76	20.2%	11.6%	3.8	3.5
2022Q3	98	55	38.5%	1.58	21.97	23.2%	12.2%	3.9	3.7
2022Q2	94	50	40.3%	1.46	20.24	20.8%	11.7%	1.4	1.3
2022Q1	93	55	34.7%	1.70	21.93	15.5%	9.1%	3.2	3.1
2021Q4	93	52	38.0%	1.56	20.78	15.7%	8.9%	5.5	5.2
2021Q3	97	48	43.9%	1.38	19.48	15.0%	7.9%	1.1	0.9
2021Q2	95	56	34.5%	2.07	22.59	13.6%	7.6%	2.7	2.7
2021Q1	95	56	34.0%	1.99	22.63	15.4%	9.2%	3.3	3.2
2020Q4	94	54	35.1%	1.88	21.92	16.8%	9.8%	2.2	2.0
2020Q3	93	52	37.8%	1.73	20.82	12.9%	7.4%	1.1	-0.1
2020Q2	93	50	40.4%	1.41	20.07	15.3%	8.5%	-0.4	-0.6
2020Q1	95	57	34.0%	1.77	23.02	14.5%	9.2%	2.3	2.3
2019Q4	96	56	35.4%	1.64	22.40	15.8%	9.7%	3.4	3.1
2019Q3	95	56	35.5%	1.59	22.35	22.4%	13.4%	4.5	4.4
2019Q2	92	53	36.5%	1.59	21.17	24.2%	13.6%	1.7	1.7
2019Q1	91	61	26.4%	2.73	24.62	25.2%	16.3%	2.5	2.4
2018Q4	91	58	29.4%	2.36	23.34	25.9%	15.8%	4.3	4.1
2018Q3	90	55	32.1%	2.12	22.06	32.5%	18.4%	1.3	1.2
2018Q2	94	52	38.9%	1.81	20.80	32.9%	17.4%	0.8	0.7
2018Q1	92	58	30.3%	2.14	23.24	24.5%	15.0%	4.3	4.2
2017Q4	95	55	35.7%	1.80	22.11	24.7%	14.3%	3.7	3.3
2017Q3	95	49	41.1%	1.87	19.87	21.9%	11.8%	2.1	2.0
2017Q2	93	47	43.4%	1.62	19.06	21.5%	11.2%	2.2	2.0
2017Q1	92	55	33.5%	2.23	22.07	21.0%	12.8%	1.9	1.8
2016Q4	93	54	35.3%	2.05	21.63	–	–	-1.5	-1.8
2016Q3	89	50	38.0%	1.61	20.08	–	–	2.5	2.2